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The data included here support the research article “Circulating
endothelial microparticles are elevated in bicuspid aortic valve
(BAV) disease and related to aortic dilation” (Alegret et al., 2016
[1]) where circulating levels of platelet endothelial cell adhesion
molecule (PECAMþ) endothelial microparticles (EMPs) were
identiﬁed as a biological variable related to aortic dilation in
patients with BAV disease. The data presented in this article are
composed by four tables and one ﬁgure containing the clinical and
echocardiographic characteristics of the patients (Alegret et al.,
2016 [1]) included in this study, and summarize the results of
multivariate linear analyses. Furthermore, is also included a ﬁgure
showing a representative ﬂow cytometry dot plots and histograms
used in PECAMþ EMPs quantiﬁcation is also included.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
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egret).
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Dubject area Biology
ore speciﬁc
subject areaCardiologyype of data Table, ﬁgure
ow data was
acquiredFlow cytometer; EPICS-XL (Beckman Coulter)ata format Analyzed
xperimental
factorsEndothelial microparticles were isolated from platelet-poor plasma from healthy
controls and patients with bicuspid aortic valve (BAV) with or without aortic
dilation.xperimental
featuresClinical and echocardiographic characteristics were determined for healthy
controls and patients with bicuspid aortic valve (BAV) with or without aortic
dilation.ata source
locationSpainata accessibility Data are within this articleDValue of the data The data provide a novel biological variable related to aortic dilation in the setting of BAV disease.
 From the quantiﬁcation of the circulating PECAMþ EMP levels new biomarkers of aortic dilation
and endothelial dysfunction in BAV disease can emerge.
 The data provide a link between BAV disease and endothelial aortic root damage and aortic
dilation.1. Data
The article includes the clinical and echocardiographic characteristics of the patients included in
the study [1], and the summaries of the results of multivariate linear analyses. Furthermore, is also
included a ﬁgure showing a representative ﬂow cytometry dot plots and histograms used in PECAMþ
EMPs quantiﬁcation.2. Experimental design, materials and methods
2.1. Study population
This article includes a cohort of patients with BAV and patients with aortic dilation who were
prospectively included and followed-up in our facilities. There were 185 patients with BAV and 125
patients with aortic dilation with tricuspid aortic valve (TAV). The participants were prospectively
entered into a speciﬁc database and provided a blood sample upon enrollment and written
acceptance.
The experimental design included four evaluations to determine data related to the EMP circulating
levels and BAV disease and are completely described in the research article “Circulating endothelial
microparticles are elevated in bicuspid aortic valve disease and related to aortic dilation” [1].
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EDTA(K3)-blood samples were collected following overnight fasting and were processed within
90 min of collection. Samples were centrifuged at 1500g for 15 min to obtain plasma, which was
further centrifuged at 4000g for 10 min to obtain platelet-poor plasma. The samples were stored at
80 °C until needed in our biological samples bank (Biobanc IISPV - HUSJR).
The concentration of circulating EMPs was determined on an EPICS-XL (Beckman Coulter) ﬂow
cytometer at low rate setting and 30 s stop time. The Nano Fluorescent Particle Size Standard Kit
(Spherotech) was used for instrument standardization and the Flow-Count ﬂuorospheres (Beckman
Coulter) were added as an internal calibrator to calculate microparticles amount.
Plasma EMPs were labeled by incubating 50 μl of platelet-poor plasma with the corresponding
antibody: anti-CD31-PE (Beckman Coulter), anti-CD42b-FITC (Beckman Coulter) and anti-CD45-PE
(Beckman Coulter) at room temperature in the dark for 20 min as previously described [2]; 500 μl of
PBS was subsequently added, and the EMP levels were determined quantiﬁed as previously described
[2–4]. Anti-CD62E-PC5 (Abcam) was used in order to determine the EMPs released from activated
endothelial cells (E-selectinþ). Microparticles that expressed phosphatidylserine were labeled using
the Annexin V apoptosis kit (Abcam) in the presence of CaCl2 according to the manufacturer's
recommendations.
Once microparticles were labeled appropriately, events o1 μmwere identiﬁed via forward scatter
and side scatter intensity dot representations using gated microparticles and plotted on either one- or
two-color ﬂuorescence histograms (Supplementary Fig. 1). EMPs were deﬁned as particles 40.1 and
o1 μm in size and the endothelial origin was identiﬁed based on its afﬁnity to CD31þCD42b
(PECAMþ), speciﬁc cell surface antigens. In order to determine the possible contamination of
leukocyte-derived microparticles the circulating levels of CD31þCD45þ was determined in all sam-
ples obtaining levels o4.5% of CD31þ microparticles co-expressing CD45þ , this results are in
accordance to that observed previously by other authors [5,6]. EMP levels were measured by trained
technicians in a blinded fashion to clinical statutes of the patients as well as to the results.2.3. Statistical analysis
Because of the right-skewed distribution of the values, the EMP plasma levels underwent a natural
logarithmic transformation and were expressed as log-transformed counts per μl (log EMPs/μl). The
quantitative variables are represented as means7SDs. The means of two groups were compared
using Student's t-test. Chi-squared tests, or Fisher exact test when appropriate, were used to compare
the frequencies of the categorical variables. Backward linear regression models were used to identify
independent predictors of the circulating PECAMþ EMP levels. P valueso0.05 were considered sig-
niﬁcant. The statistical analysis was performed using SPSS software, version 21.0 (IBM, Chicago,
IL, USA).Acknowledgments
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